Maulik Patel
#770Chairman & Managing Director
40
Age
20y
Exp
10y
Tenure
7/10
Risk
🎓 B.E. in Chemical Engineering · University of Southern California
📜 M.S. in Chemical Engineering · University of Southern California
🏛️ None
CompensationTBP
Personality
7
Open
7
Cons
5
Extr
5
Agre
4
Neur
Epigral
Basic Materials · Small Cap
High Growth · Performance-Driven
About
Maulik Patel is the Chairman & Managing Director of Epigral, a Small Cap company in the Basic Materials sector with a market cap of ₹4K Cr. A Transformational leader with 20 years of experience, he is known for authority-driven decision-making and organic builder strategy. Aggressively repositioned the company toward high-margin specialty chemicals with a clear pivot from commodity manufacturing.
FAQ
What is Maulik Patel's leadership style?
Maulik Patel is classified as a Transformational leader. He is authority-driven in decision-making, with a category creator motivation and startup-speed pace of execution.
What is Maulik Patel's educational background?
Maulik Patel holds a B.E. in Chemical Engineering from University of Southern California and a M.S. in Chemical Engineering from University of Southern California.
Who is the CEO of Epigral?
Maulik Patel is the Chairman & Managing Director of Epigral. He has been with the company for 10 years and in the current role for 5 years.
Leadership DNA
ArchetypeTransformational
MotivationCategory Creator
CrisisRestructurer
DecisionAuthority-Driven
GrowthOrganic Builder
PeopleNumbers Driven
InnovationFast-Follower
PaceStartup-Speed
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerDemanding Machine
BrandTechnical-Expert
FocusProduct Innovation
OrientationDeep Specialist
Leadership Evidence
“Aggressively repositioned the company toward high-margin specialty chemicals with a clear pivot from commodity manufacturing.”
⚡ Crisis●●●●○
He spearheaded the strategic transition of the company from Meghmani Finechem to Epigral, divesting from legacy commodity segments to focus on high-margin specialty chemicals.
🎯 Motivation●●●●○
He pivoted the company's focus toward becoming a leader in complex specialty chemicals like Epichlorohydrin and CPVC resin, products previously reliant on imports.
👥 People●●●○○
His leadership style is characterized by a rigorous focus on operational efficiency and performance-linked KPIs to drive the company's aggressive capacity expansion.
📈 Growth●●●●○
The company's growth has been primarily driven by massive, phased greenfield investments in integrated manufacturing complexes in Dahej.
💡 Innovation●●●●○
Epigral has successfully transitioned from a commodity-focused player to a specialty chemical manufacturer by scaling production of high-margin derivatives like CPVC resin and chlorotoluenes.
🏃 Pace●●●●○
The company has demonstrated rapid execution in commissioning new large-scale chemical plants and diversifying its product portfolio within a very short timeframe.
🌱 Purpose●●●●○
The company's strategic focus is heavily centered on capacity expansion, margin improvement, and operational efficiency within the chemical manufacturing sector.
🏷️ Brand●●●●○
The company is recognized for its deep process engineering capabilities and its ability to manufacture complex chemical derivatives at scale.
🤝 Customer●●●●●
Epigral operates as a key supplier of specialty chemicals and derivatives to various industrial sectors including pharmaceuticals, agrochemicals, and polymers.
💼 Employer●●●○○
As a high-growth chemical manufacturer undergoing rapid expansion, the culture emphasizes aggressive operational targets and high-performance standards.
📋 Mandate
As a specialty chemicals player, moving up the value chain through R&D-led product innovation is critical to differentiate from commodity peers.
🏢 Culture●●●○○
Chemical sector manufacturer characterized by rapid capacity expansion and performance-oriented operational strategies under leadership.
Financials
Revenue FY25₹3K Cr
PAT FY25₹358 Cr
Rev CAGR 5Y17.5%
OPM23%
NPM14.2%
ROE18.8%
ROCE21.7%
P/E11.1
Fwd P/E10.8
P/B1.8
D/E25.6
Promoter68.9%
Institutional6.1%
Mkt Cap₹4K Cr
Compensation
To Be Published
Data being verified from audited reports
